Product Specification
| Alternative Name: | Intelectin-1, Intestinal lactoferrin receptor, Galactofuranose-binding lectin, Endothelial lectin HL-1 |
| |
| Concentration: | 1mg/ml |
| |
| Purity Detail: | Protein G-affinity purified. |
| |
| Purity: | ≥95% (SDS-PAGE) |
| |
| Formulation: | Liquid. In PBS containing 0.02% sodium azide. |
| |
| Clone: | Saly-1 |
| |
| Isotype: | Mouse IgG2b |
| |
| Immunogen: | Recombinant human omentin 1 (intelectin-1) (aa 17-231). |
| |
| Source/Host: | Purified from concentrated hybridoma tissue cell culture supernatant. |
| |
| Specificity: | Recognizes human omentin 1. |
| |
| Application: | ELISA (capture) Immunohistochemistry (paraffin sections) Western Blot (1:1'000) |
| |
| Short Term Storage: | +4°C |
| |
| Long Term Storage: | -20°C |
| |
| Use/Stability: | Stable for at least 1 year after receipt when stored at -20°C. |
| |
| Handling: | After opening, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles. |
| |
| Miscellaneous/General: | Omentin 1 (also named intelectin-1, endothelial lectin HL-1 and intestinal lactoferrin receptor) has been identified as a visceral fat (or omental fat) depot-specific adipokine. Omentin 1 is a secreted protein of ~38 kDa containing a fibrinogen-related domain. Omentin 1 is highly expressed in the omental fat, and much less in intestine, lung and heart. Addition of recombinant omentin in vitro did not affect basal, but enhanced insulin-stimulated glucose uptake in subcutaneous as well as in omental human adipocytes. Omentin 1 triggers AKT signalling in the absence of insulin. |
| |
Figure: Immunohistochemical staining of endogenous human Omentin 1 in different human tissues (paraffin sections) using MAb to Omentin 1 (Saly-1) (Prod. No.
ALX-804-850).
Method: Different human normal tissues (A: Rectum; B: Small Intestine; C: Stomach) or cancer tissues (D: Colorectal cancer) were stained with MAb to Omentin 1 (Saly-1) by standard immunohistochemistry.
Pictures courtesy of Human Protein Atlas (www.proteinatlas.org).
Please mouse over
Product Literature References
Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose: B.K. Tan, et al.; Diabetes
57, 801 (2008),
Abstract;
General Literature References
Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action: R.Z. Yang, et al.; Am. J. Physiol. Endocrinol. Metab.
290, E1253 (2006),
Abstract;